Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Benzydamine Hydrochloride
Therapeutic Area : Gastroenterology
Study Phase : Phase I/ Phase II
Sponsor : Hematology Center after Prof. R. Yeolyan
Deal Size : Inapplicable
Deal Type : Inapplicable
Study for the Prevention of Oral Mucositis (SPOM)
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 21, 2022
Lead Product(s) : Benzydamine Hydrochloride
Therapeutic Area : Gastroenterology
Highest Development Status : Phase I/ Phase II
Sponsor : Hematology Center after Prof. R. Yeolyan
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Benzydamine Hydrochloride
Therapeutic Area : Gastroenterology
Study Phase : Phase IV
Sponsor : PPD
Deal Size : Inapplicable
Deal Type : Inapplicable
Benzydamine Oromucosal Solution in Oral Mucositis (BOOM)
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 24, 2021
Lead Product(s) : Benzydamine Hydrochloride
Therapeutic Area : Gastroenterology
Highest Development Status : Phase IV
Sponsor : PPD
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Benzydamine Hydrochloride
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Sponsor : Zak-Pharma Dienstleistung Ges.m.b.H.
Deal Size : Inapplicable
Deal Type : Inapplicable
Benzydamine in Sore Throat Pain Relief (BePaiR Study)
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 28, 2021
Lead Product(s) : Benzydamine Hydrochloride
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Sponsor : Zak-Pharma Dienstleistung Ges.m.b.H.
Deal Size : Inapplicable
Deal Type : Inapplicable